Latest filings (excl ownership)
10-K/A
2023 FY
Annual report (amended)
26 Apr 24
8-K
Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
25 Apr 24
8-K
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
18 Mar 24
10-K
2023 FY
Annual report
1 Mar 24
8-K
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
28 Feb 24
EFFECT
Notice of effectiveness
8 Feb 24
EFFECT
Notice of effectiveness
8 Feb 24
CORRESP
Correspondence with SEC
5 Feb 24
CORRESP
Correspondence with SEC
5 Feb 24
S-3/A
Shelf registration (amended)
2 Feb 24
UPLOAD
Letter from SEC
1 Feb 24
UPLOAD
Letter from SEC
1 Feb 24
S-3
Shelf registration
19 Jan 24
S-3
Shelf registration
19 Jan 24
S-8
Registration of securities for employees
19 Jan 24
S-8
Registration of securities for employees
19 Jan 24
8-K/A
Financial Statements and Exhibits
19 Jan 24
8-K
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue
8 Jan 24
8-K
Standard BioTools Stockholders Approve Merger with SomaLogic
5 Jan 24
425
Business combination disclosure
29 Dec 23
8-K
Glass Lewis Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
29 Dec 23
425
Business combination disclosure
22 Dec 23
8-K
ISS Recommends Standard BioTools Stockholders Vote “FOR” All Proposals Relating to Proposed Merger with SomaLogic
22 Dec 23
424B3
Prospectus supplement
21 Dec 23
425
Business combination disclosure
19 Dec 23
8-K
Investor Presentation Unlocking Value in a Fragmented Space DECEMBER 2023
19 Dec 23
425
Business combination disclosure
4 Dec 23
8-K
Standard BioTools and SomaLogic Announce Date for Special Meetings of Stockholders to Vote on Proposed Merger
4 Dec 23
EFFECT
Notice of effectiveness
4 Dec 23
424B3
Prospectus supplement
1 Dec 23
CORRESP
Correspondence with SEC
1 Dec 23
425
Business combination disclosure
28 Nov 23
8-K
Standard BioTools Activating Strategy to Become a Diversified Leader in Life Sciences Tools NOVEMBER 2023
28 Nov 23
UPLOAD
Letter from SEC
27 Nov 23
425
Business combination disclosure
21 Nov 23
8-K
Other Events
21 Nov 23
S-4
Registration of securities issued in business combination transactions
13 Nov 23
CORRESP
Correspondence with SEC
13 Nov 23
425
Business combination disclosure
7 Nov 23
Latest ownership filings
4
Michael Egholm
9 Apr 24
4
Michael Egholm
5 Apr 24
4
Hanjoon Alex Kim
5 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
SC 13G/A
VIKING GLOBAL INVESTORS LP
20 Mar 24
3
OLE ANDREAS HALVORSEN
20 Mar 24
4
Eli Casdin
20 Mar 24
SC 13D/A
Casdin Capital, LLC
20 Mar 24
144
Notice of proposed sale of securities
19 Mar 24
144
Notice of proposed sale of securities
18 Mar 24
144
Notice of proposed sale of securities
14 Mar 24
4
Eli Casdin
6 Mar 24
SC 13G
MILLENNIUM MANAGEMENT LLC
26 Feb 24
4
Eli Casdin
22 Feb 24
SC 13G/A
Indaba Capital Management, L.P.
14 Feb 24
SC 13G
VANGUARD GROUP INC
13 Feb 24
SC 13D/A
Neuberger Berman Group LLC
12 Jan 24
4
Change in insider ownership
9 Jan 24
4
Eli Casdin
9 Jan 24
4
Troy Cox
9 Jan 24
4
Thomas D. Carey
9 Jan 24
4
KATHY L HIBBS
9 Jan 24
3
Thomas D. Carey
9 Jan 24
3
KATHY L HIBBS
9 Jan 24
3
Troy Cox
9 Jan 24
SC 13D/A
Casdin Capital, LLC
9 Jan 24
SC 13G
VIKING GLOBAL INVESTORS LP
9 Jan 24
SC 13D/A
Caligan Partners LP
8 Jan 24
SC 13D/A
VIKING GLOBAL INVESTORS LP
22 Nov 23
4
Martin D Madaus
20 Oct 23
SC 13D
VIKING GLOBAL INVESTORS LP
16 Oct 23
144
Notice of proposed sale of securities
23 Aug 23
144
Notice of proposed sale of securities
17 Aug 23
144
Notice of proposed sale of securities
11 Aug 23
SC 13G/A
PRIMECAP MANAGEMENT CO/CA/
7 Jul 23
4
DAVID EDWARD JOHNSON
3 Jul 23
SC 13D/A
Caligan Partners LP
3 Jul 23
4
Martin D Madaus
16 Jun 23
4
Eli Casdin
16 Jun 23